Rockwell Medical (RMTI) Total Liabilities (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Total Liabilities came in at $21.6 million in Q1 2026, down 3.89% YoY from $22.4 million in Q1 2025, and up 6.95% on a QoQ basis from $20.2 million in Q4 2025.
Rockwell Medical (RMTI) Total Liabilities (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Total Liabilities data on file, last reported at $21.6 million in Q1 2026.
- Quarterly Total Liabilities fell 3.89% year-over-year to $21.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.6 million (down 3.89% YoY) and the FY2025 annual result came in at $20.2 million, down 24.26% from the prior year.
- Total Liabilities rose to $21.6 million in Q1 2026, from $20.2 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $42.2 million in Q1 2022 to a low of $20.2 million in Q4 2025.
- A 5-year average of $28.9 million and a median of $28.5 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities slumped 33.88% — and 2024, when it rose 7.7%.
- Tracing RMTI's Total Liabilities over 5 years: stood at $32.5 million in 2022, then retreated by 5.06% to $30.9 million in 2023, then retreated by 13.79% to $26.6 million in 2024, then declined by 24.26% to $20.2 million in 2025, then gained by 6.95% to $21.6 million in 2026.
- The last three Total Liabilities figures came in at $21.6 million (Q1 2026), $20.2 million (Q4 2025), and $20.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn | 21.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.44 Mn |
| Mar 31, 2026 | 21.57 Mn |
| Dec 31, 2025 | 20.16 Mn |
| Sep 30, 2025 | 20.47 Mn |
| Jun 30, 2025 | 22.22 Mn |
| Mar 31, 2025 | 22.44 Mn |
| Dec 31, 2024 | 26.62 Mn |
| Sep 30, 2024 | 27.95 Mn |
| Jun 30, 2024 | 29.53 Mn |
| Mar 31, 2024 | 30.08 Mn |
| Dec 31, 2023 | 30.88 Mn |
| Sep 30, 2023 | 31.09 Mn |
| Jun 30, 2023 | 28.51 Mn |
| Mar 31, 2023 | 27.93 Mn |
| Dec 31, 2022 | 32.53 Mn |
| Sep 30, 2022 | 38.05 Mn |
| Jun 30, 2022 | 38.97 Mn |
| Mar 31, 2022 | 42.24 Mn |
| Dec 31, 2021 | 46.04 Mn |
| Sep 30, 2021 | 47.61 Mn |